Topic
Menopause & HRT
Hormone therapy, hot flashes, sleep and mood. Plain-language summaries of what randomized evidence shows about hormonal and non-hormonal menopause care.
Start here
Hot flashes & night sweats
- Vasomotor Symptoms of Menopause: Hot Flashes and Night SweatsVasomotor symptoms of menopause are hot flashes and night sweats. They can feel like sudden heat, flushing, sweating, chills afterward, sleep disruption, and daytime fatigue. In Study of Women's Health Across the Nation, frequent symptoms lasted a median 7.4 years and persisted 4.5 years after the final menstrual period. Treatment depends on severity, sleep impact, age, time since menopause, uterus status, contraindications, medicines, and preference. Hormone therapy is most effective for appropriate candidates; nonhormonal options include antidepressant-class medicines, gabapentin, fezolinetant, elinzanetant, oxybutynin, cognitive behavioral therapy, and hypnosis. [1] [3] [4] [5] [6] [7] [8]
- Why Are Hot Flashes Worse at Night?Hot flashes often feel worse at night because the same vasomotor symptom is happening during sleep: it wakes you, soaks bedding, raises anxiety about falling back asleep, and may be amplified by alcohol, warm rooms, bedding, reflux, medications, or sleep apnea. The bigger point is duration and pattern: in Study of Women's Health Across the Nation, frequent hot flashes or night sweats lasted a median 7.4 years, and persisted a median 4.5 years after the final menstrual period. [1] New, drenching, unexplained, or night-only sweats with fever, weight loss, cough, chest symptoms, lymph nodes, or abnormal bleeding should be evaluated before assuming menopause. [5]
- Antidepressant-class medicines for Hot Flashes After MenopauseAntidepressant-class medicines can be evidence-supported nonhormonal options for menopause hot flashes, but they are not interchangeable. The 2023 North American Menopause Society statement lists selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as recommended nonhormonal therapies for vasomotor symptoms. In MsFLASH, venlafaxine ER 75 mg/day reduced symptoms by 47.6% over 8 weeks versus 28.6% with placebo. Low-dose paroxetine 7.5 mg is FDA-labeled for moderate to severe menopausal vasomotor symptoms, but tamoxifen interaction and drug warnings change who fits. [3] [6]
- Oxybutynin for Hot Flashes: Anticholinergic TradeoffsOxybutynin is an off-label prescription option for menopause hot flashes, not an FDA-labeled menopause drug. In a 148-woman 12-week randomized trial, 15 mg extended-release oxybutynin reduced moderate-to-severe vasomotor symptoms by 9.48 episodes per day versus 4.69 with placebo, but dry mouth occurred in 52.1% of participants on oxybutynin versus 5.3% on placebo. The decision should include anticholinergic burden, constipation, urinary retention, glaucoma, cognitive concerns, age, and the medication list. [2]
- How Long Do Hot Flashes Last? Seven Years Is Not RareHot flashes and night sweats can last years, not just a few months. In Study of Women's Health Across the Nation, 1,449 women had frequent vasomotor symptoms; the median total duration was 7.4 years, and symptoms persisted a median 4.5 years after the final menstrual period. Women whose frequent symptoms began before or early in perimenopause had the longest course, with median total duration longer than 11.8 years. [1] Persistent symptoms deserve treatment review, not dismissal.
- Gabapentin for Hot Flashes: Benefits and Side EffectsGabapentin is a prescription medication sometimes used off-label for menopausal hot flashes. In a 197-participant randomized trial, gabapentin 900 mg/day reduced hot flash scores by 51% over 4 weeks versus 26% with placebo. [1] In another 59-woman trial, gabapentin 900 mg/day reduced hot flash frequency by 45% and a composite hot-flash score by 54% at 12 weeks, compared with 29% and 31% for placebo. [2] The 2023 Menopause Society nonhormone statement lists gabapentin as a Level I recommended nonhormonal option, but the decision still needs screening for sedation, dizziness, falls, kidney function, opioids, other central nervous system depressants, respiratory risk, mood changes, and tapering. [3] [7]
- Fezolinetant vs Hormone Therapy for Hot Flashes After MenopauseFezolinetant is a nonhormonal prescription treatment for moderate to severe hot flashes due to menopause. Phase 3 trials showed about two to three fewer moderate to severe vasomotor symptoms per day versus placebo by weeks 4 and 12. It should not be described as "better than hormone replacement therapy" because the pivotal trials were placebo-controlled, not head-to-head against menopausal hormone therapy. The current VEOZAH label also has a boxed warning for hepatotoxicity and requires baseline and follow-up liver testing. [4]
- Clonidine for Hot Flashes: Blood-Pressure TradeoffsClonidine is an older off-label prescription option for menopause hot flashes, but it is not a first-choice nonhormonal treatment. The 2023 North American Menopause Society nonhormone statement lists clonidine among therapies not recommended for vasomotor symptoms. Older trials did find modest benefit: an 8-week transdermal trial reported fewer hot flashes in 80% of clonidine users versus 36% on placebo, and a JAMA meta-analysis estimated about 0.95 fewer hot flashes per day versus placebo. Because clonidine is labeled for hypertension and can cause withdrawal blood-pressure problems if stopped suddenly, it belongs in clinician review, not casual self-treatment. [1]
- Hot Flashes and Bone Density After MenopauseHot flashes and night sweats do not diagnose osteoporosis, but they can be a bone-risk clue after menopause. A 2024 systematic review and meta-analysis of 20 observational studies found vasomotor symptoms associated with higher odds of low bone mineral density, especially when moderate or severe, but not with higher pooled fracture risk. The useful next step is to ask whether symptom severity plus age, early menopause, fracture history, medicines, body weight, smoking, falls, or family history justify earlier bone-density testing or a fracture-risk plan. [1] [2] [3]
HRT options, safety & side effects
- Low Estrogen Symptoms After 40: Pattern, Tests, and Treatment FitLow estrogen after 40 can show up as hot flashes, night sweats, sleep disruption tied to heat surges, vaginal dryness, painful sex, urinary symptoms, and cycle changes during perimenopause. But low estrogen is not the safest explanation for every midlife symptom. The useful first step is to sort the pattern: vasomotor symptoms, genitourinary symptoms, bleeding, bone risk, mood and sleep, thyroid or iron clues, medicines, and metabolic risk. American College of Obstetricians and Gynecologists guidance says hormone testing is usually not needed when age, symptoms, and period changes fit perimenopause. Treatment should follow symptom category and contraindication review, not a single estrogen number. [1] [2]
- Vaginal Estrogen After Menopause: Dryness, UTIs, and SafetyVaginal estrogen after menopause is usually a local genitourinary syndrome of menopause decision, not the same decision as systemic hormone replacement therapy for hot flashes. Menopause Society says genitourinary syndrome of menopause affects about 27% to 84% of postmenopausal women, and low-dose vaginal estrogen is an effective option for moderate to severe symptoms. For recurrent UTIs, the 2025 AUA/CUA/SUFU guideline says peri- and postmenopausal women with recurrent UTIs should be recommended vaginal estrogen therapy to reduce future UTI risk if there is no contraindication. Safety still depends on bleeding, cancer history, clot/stroke history, liver disease, product dose, and whether symptoms are truly genitourinary syndrome of menopause. [1]
- Transdermal vs Oral Estrogen: Clot-Risk DifferencesRoute can matter in menopausal hormone therapy. Observational evidence and clinical guidance suggest oral estrogen is linked with higher venous clot risk than transdermal estrogen, while transdermal estrogen may have less prothrombotic effect. That does not make patches safe for everyone. A clinician still has to screen clot history, stroke, heart disease, cancer history, uterus status, dose, progestogen choice, and timing since menopause. [1]
- Progesterone vs Progestin in HRT: What ChangesProgesterone and synthetic progestins are both progestogens, but they should not be treated as interchangeable risk profiles. If a woman with a uterus uses systemic estrogen, endometrial protection is required: the Prometrium label reports endometrial hyperplasia in 6% of women using cyclic progesterone plus conjugated estrogens versus 64% using conjugated estrogens alone. [1] The Women's Health Initiative tested one specific oral regimen and found excess risks after a mean 5.2 years; observational data suggest micronized progesterone may differ from some synthetic progestins, but those data do not erase hormone-therapy risk. [2] [3] [4]
- Micronized Progesterone for Sleep After MenopauseMicronized progesterone has a real but bounded sleep signal. A 2021 systematic review found 9 randomized trials with 388 participants, mostly postmenopausal women, and sleep-onset latency improved in a 4-trial meta-analysis. But total sleep time and sleep efficiency were not clearly improved, and some trials combined progesterone with estradiol or improved hot flashes at the same time. [1]
- HRT Side Effects After Menopause: What to Watch ForHormone replacement therapy side effects depend on hormone, route, dose, uterus status, age, and risk history. Nuisance effects can include breast tenderness, headache, nausea, bloating, fluid retention, mood change, spotting, or patch irritation, but the high-stakes questions are bleeding, breast cancer history, clot or stroke risk, heart disease, liver disease, gallbladder symptoms, migraine pattern, and endometrial protection. In Women's Health Initiative estrogen plus progestin, hazard ratios were 1.29 for coronary heart disease, 1.26 for invasive breast cancer, 1.41 for stroke, and 2.13 for pulmonary embolism. [3] In estrogen-alone Women's Health Initiative, stroke risk rose and hip-fracture risk fell. [4]
- HRT After Hysterectomy: Estrogen Alone Is a Different QuestionHormone replacement therapy after hysterectomy is not the same decision as hormone replacement therapy with an intact uterus. A current estradiol transdermal label says a woman without a uterus generally does not need a progestogen with estrogen, but endometriosis history can be an exception. The Women's Health Initiative also kept the evidence separate: estrogen alone was studied in 10,739 women with prior hysterectomy, while estrogen plus progestin was studied in 16,608 women with an intact uterus. The practical answer is anatomy first, then symptom goal, age, route, clot/stroke/cancer history, and follow-up plan. [3]
- HRT After 65: Review Risks, Do Not Stop by Age AloneHormone replacement therapy does not have one automatic stop date. Menopause Society says risks differ by type, dose, route, duration, timing, and progestogen use, and that continuing therapy should be periodically reevaluated. American College of Obstetricians and Gynecologists recommends against routine discontinuation of systemic estrogen at age 65 for women who still need it for vasomotor symptoms. [1]
- Bioidentical HRT: FDA-Approved vs CompoundedBioidentical hormone replacement therapy can mean FDA-approved estradiol or micronized progesterone products, or custom-compounded hormones marketed as natural or individualized. A 2023 American College of Obstetricians and Gynecologists Clinical Consensus says safety and effectiveness marketing claims for compounded bioidentical menopausal hormone therapy lack support and that these products should not be prescribed routinely when FDA-approved options exist. [1] A 2022 review found inadequate evidence for breast cancer, endometrial cancer, or cardiovascular outcomes. [3] The safer question is whether a clinician can document a patient-specific reason for compounding. [7]
- Does HRT Help Brain Fog? Menopause Cognition EvidenceHormone replacement therapy should not be used as a primary treatment for brain fog or as a dementia-prevention strategy after natural menopause. The Menopause Society says hormone therapy is not recommended to improve cognition for women who undergo natural menopause, and its 2022 position statement says later initiation has a less favorable benefit-risk ratio partly because dementia risk rises with age and time since menopause. [1] [2] Brain fog is still real: perimenopause research points to verbal learning and verbal memory changes, and sleep, mood, and hot flashes can worsen concentration. [3]
- Oral vs Transdermal Estrogen: Metabolic Tradeoffs After MenopauseRoute can matter, but not as a simple "patches are better than pills" rule. A 2026 meta-analysis of 8 randomized clinical trials with 885 participants found oral estrogen raised high-density lipoprotein cholesterol more than transdermal estrogen, but also raised triglycerides more; blood pressure, heart rate, total cholesterol, and low-density lipoprotein cholesterol did not differ significantly by route. [1] Route still has to be matched to symptoms, uterus status, baseline lipids, clot and stroke risk, age, timing since menopause, and progestogen plan. [2] [3] [4]
Non-hormonal options
Mood & sleep
Joint & body changes
- Menopause Weight Gain: What Changes and What to CheckMenopause can change body composition and waist distribution, but it rarely explains weight gain by itself. Study of Women's Health Across the Nation data found fat gain accelerated and lean mass declined around the menopause transition, while scale-weight gain did not clearly accelerate at transition onset. Study of Women's Health Across the Nation Heart data found visceral abdominal fat rose fastest around the final menstrual period. The useful next step is to measure waist, body mass index, blood pressure, lipids, glucose risk, sleep symptoms, medications, protein, resistance training, bone risk, and treatment category. [1] [2]
- Joint Pain Causes After Menopause: What to Rule OutJoint pain causes after menopause include osteoarthritis, tendon or muscle overload, inflammatory arthritis, thyroid or iron problems, medication changes, recent illness or weight loss, and menopause-related aches that may overlap with hot flashes, poor sleep, and lower estrogen. Hormone replacement therapy is not a joint-pain diagnostic test. In a Women's Health Initiative estrogen-alone analysis, joint pain was modestly less frequent after 1 year with estrogen than placebo, but joint swelling was more frequent, so persistent swelling, prolonged morning stiffness, hand or foot synovitis, fever, trauma, rapidly worsening pain, or a hot swollen joint should be evaluated instead of treated as menopause alone. [1] [2] [3] [6]
- Early Menopause Before 45: What to Check Beyond SymptomsMenopause before 45 deserves clinician review because the issue is not only hot flashes. Early menopause usually means ovarian function stops from age 40 through 44, while premature ovarian insufficiency means ovarian insufficiency before 40. The review should cover pregnancy and other causes of missed periods, bone density and fracture risk, cardiovascular risk, fertility and contraception, genitourinary symptoms, mood, sleep, and whether hormone therapy is appropriate. American College of Obstetricians and Gynecologists guidance says hormone therapy in primary ovarian insufficiency is indicated to reduce osteoporosis, cardiovascular, and urogenital risks when no contraindication exists. [1] [2] [3]
- Hormone Therapy and Bone Density After Menopause: Does It Help?Hormone therapy can help preserve bone density after menopause and reduce fracture risk in selected women, especially when treatment is started before age 60 or within 10 years of menopause and there are no contraindications. It should not be treated as the default answer for established osteoporosis, prior hip or spine fracture, or very high fracture risk. The safer sequence is screening and fracture-risk classification first, then a clinician-led decision about whether hormone therapy, osteoporosis-specific medication, lifestyle, or monitoring best fits the case. [1] [2] [3] [4]
Early & surgical menopause
More in Menopause & HRT
- Will Menopause Symptoms Go Away? What Usually ChangesSome menopause symptoms fade, but not on one timeline. Hot flashes and night sweats often improve, yet Study of Women's Health Across the Nation found frequent vasomotor symptoms lasted a median 7.4 years, including 4.5 years after the final menstrual period. Vaginal and urinary symptoms from genitourinary syndrome of menopause can persist and are treatable. Bleeding after 12 months without a period, heavy bleeding, new drenching sweats, fever, weight loss, chest symptoms, or severe mood symptoms should be evaluated instead of watched. The next step is symptom-category triage with a clinician. [1] [2] [5] [9] [10] [11]
- How Long Does the Menopause Usually Last?Menopause itself is confirmed after 12 months without a period when pregnancy, hormonal contraception, surgery, medication, or another cause is not explaining the pattern. The transition before that can last years: the Office on Women's Health describes perimenopause as 2 to 8 years, with about 4 years typical, and Study of Women's Health Across the Nation calendar data found adjusted median transition duration from 4.37 to 8.57 years depending on age at onset. Hot flashes have a separate clock; in Study of Women's Health Across the Nation, frequent vasomotor symptoms lasted a median 7.4 years overall and 4.5 years after the final menstrual period. [1] [2] [5]
- Prasterone After Menopause: Painful Sex, Fit, and LimitsPrasterone, sold as INTRAROSA, is a prescription vaginal insert approved for moderate to severe dyspareunia caused by vulvar and vaginal atrophy after menopause. Trials and pooled analyses support symptom and tissue-marker improvement in this specific genitourinary syndrome of menopause use. That does not make prasterone systemic hormone replacement therapy, a libido drug, or a general menopause treatment. Pain, bleeding, infection symptoms, lesions, pelvic pain, cancer history, and medication risks need clinician review before treatment. [1]
- Ospemifene After Menopause: Painful Sex Safety ReviewOspemifene is an oral prescription selective estrogen receptor modulator used for moderate to severe dyspareunia and vaginal dryness due to menopause. It can help genitourinary syndrome of menopause symptoms in studied postmenopausal women, but it is systemic therapy, not the same as a local vaginal moisturizer, vaginal estrogen, or prasterone insert. The useful frame is ospemifene as diagnosis-first care with clinician review of bleeding, clot, stroke, cancer, medication, and vaginal-symptom history before treatment. [1]
- Menopause Symptoms After 45: Common Patterns and Red FlagsMenopause symptoms are not one symptom and not one timeline. Common patterns include hot flashes, night sweats, sleep disruption, mood changes, brain fog, vaginal dryness, painful sex, urinary urgency or recurrent UTIs, joint aches, skin and hair changes, and weight or waist changes. Cycle changes usually belong to perimenopause, while bleeding after 12 months without a period is postmenopausal bleeding and should be evaluated. The Stages of Reproductive Aging Workshop +10 (STRAW+10) framework defines the final menstrual period retrospectively after 12 months without bleeding, and American College of Obstetricians and Gynecologists guidance says hormone testing usually is not needed when age, symptoms, and period changes fit the transition. [1] [2]
- Hormone Therapy After Menopause: Benefits, Risks, and TimingHormone therapy can help bothersome hot flashes, night sweats, genitourinary syndrome of menopause, and selected bone-loss prevention decisions, especially for healthy women younger than 60 or within 10 years of menopause. Women's Health Initiative still defines the safety frame: estrogen plus progestin increased coronary, breast-cancer, stroke, and pulmonary-embolism risks, while estrogen alone in women with hysterectomy raised stroke risk and lowered hip-fracture risk. [2] [3] Route, uterus status, timing, contraindications, and personal risk decide fit. FDA-approved estradiol or micronized progesterone also differs from custom-compounded bioidentical therapy, which American College of Obstetricians and Gynecologists says should not be routine when approved options exist. [8]
- Vaginal Itching After Menopause: Dryness, Infection, or Skin?Vaginal or vulvar itching after menopause can be part of genitourinary syndrome of menopause, especially when it travels with dryness, burning, irritation, pain with sex, urinary urgency, or recurrent urinary symptoms. But itching is not specific to menopause. CDC guidance says vulvovaginal symptoms such as itching, burning, irritation, odor, or discharge often need history, exam, and laboratory testing because history alone can lead to the wrong treatment. Yeast, bacterial vaginosis, contact dermatitis, lichen sclerosus, sexually transmitted infections, urinary conditions, and lesions can overlap. [1] [4] [5] [6] [7]
Common questions
What are common low estrogen symptoms after 40?
The symptoms most plausibly tied to the menopause transition include hot flashes, night sweats, sleep disruption from heat surges, vaginal dryness, painful sex, urinary symptoms, and changing periods before the final menstrual period.
What is fezolinetant used for?
Fezolinetant is used for moderate to severe vasomotor symptoms due to menopause, meaning hot flashes and night sweats. The labeled dose is one 45 mg tablet once daily. It is not estrogen and does not treat every menopause symptom.
Do menopause symptoms eventually go away?
Some do. Hot flashes, night sweats, sleep disruption, and mood swings often improve over time, but they can last years. Vaginal and urinary symptoms may persist without targeted treatment.
What are vasomotor symptoms of menopause?
Vasomotor symptoms are hot flashes and night sweats. CDC describes hot flashes as a sudden feeling of heat in the upper body, sometimes with flushing, red blotches, heavy sweating, and chills afterward.
Does menopause cause weight gain?
Menopause can change body composition and fat distribution, but it does not explain every pound. Study of Women's Health Across the Nation data found fat gain accelerated and lean mass declined around the transition while total weight did not show the same clear acceleration. [1]
Does hysterectomy cause menopause if my ovaries were kept?
Usually not immediately. Hysterectomy removes the uterus, so periods stop, but ovaries can keep making hormones. In one prospective cohort, ovarian failure after 4 years was estimated at 14.8% after hysterectomy versus 8.0% in controls, so earlier menopause is possible.
What is menopause in simple terms?
Menopause is when periods have stopped permanently. Clinically, it is confirmed after 12 months in a row without bleeding or spotting when another cause is not explaining the pattern.
What helps hot flashes and night sweats most?
Systemic hormone therapy has the strongest evidence for appropriate candidates. A JAMA review reports systemic estrogen reduces vasomotor symptom frequency by about 75%, while nonhormonal options may fit when hormones are unsuitable.